<DOC>
	<DOC>NCT00377039</DOC>
	<brief_summary>This is a multicentre, randomized, double-blind, placebo controlled, parallel group exploratory study to investigate the efficacy, safety and tolerability of AD 337 in the treatment of fibromyalgia in female subjects.</brief_summary>
	<brief_title>A Multicentre Trial to Determine the Efficacy and Safety of AD-337 in the Treatment of Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>Female Age 1865 Meet ACR 1990 criteria for classification of Fibromyalgia Able and willing to discontinue CNS active therapies If pain is NOT primarily due to Fibromyalgia Current or prior history of serious psychiatric disorder Pregnant/breastfeeding QTc &gt; 470ms Failure to respond to 2 or more adequate regimes of different classes of antidepressants.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>ACR 1990 Fibromyalgia</keyword>
	<keyword>Fibromyalgia Impact Questionnaire</keyword>
</DOC>